JunD is involved in the antiproliferative effect of Δ9- tetrahydrocannabinol on human breast cancer cells

Oncogene

Volumn 27, Issue 37, 2008, Pages 5033-5044

  Caffarel, M M ^a   Moreno Bueno, G ^b   Cerutti, C ^a   Palacios, J ^c   Guzman, M ^a   Mechta Grigoriou, F ^d   Sanchez, C ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d INSTITUT CURIE   (France)

Author keywords

AP 1; Breast cancer; Cannabinoids; JunD; p27; Testin

Indexed keywords

TETRAHYDROCANNABINOL; TRANSCRIPTION FACTOR JUND;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-JUN; TETRAHYDROCANNABINOL; TUMOR CELLS, CULTURED; UP-REGULATION;

CANNABIS SATIVA; MUS;

EID: 50649112355     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.145     Document Type: Article

References (29)

1. Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M. (2002). Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol 22: 4952-4964.
2. Berdyshev EV, Schmid PC, Krebsbach RJ, Hillard CJ, Huang C, Chen N et al. (2001). Cannabinoid-receptor-independent cell signalling by N-acylethanolamines. Biochem J 360: 67-75.
3. Blazquez C, Carracedo A, Barrado L, Real PJ, Fernandez-Luna JL, Velasco G et al. (2006). Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 20: 2633-2635.
4. 9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res 66: 6615-6621.
5. Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G et al. (2006a). Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 66: 6748-6755.
6. Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, Giroux V et al. (2006b). The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell 9: 301-312.
7. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M et al. (1998). The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 95: 8375-8380.
8. Drusco A, Zanesi N, Roldo C, Trapasso F, Farber JL, Fong LY et al. (2005). Knockout mice reveal a tumor suppressor function for Testin. Proc Natl Acad Sci USA 102: 10947-10951.
9. Eferl R, Wagner EF. (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
10. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D et al. (2004). JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118: 781-794.
11. Giuliano M, Calvaruso G, Pellerito O, Portanova P, Carlisi D, Vento R et al. (2006). Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. Int J Mol Med 17: 811-819.
12. Guzman M. (2003). Cannabinoids: potential anticancer agents. Nat Rev Cancer 3: 745-755.
13. 9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 95: 197-203.
14. 9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95: 8268-8273.
15. Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J. (2000). Neuroprotective antioxidants from marijuana. Ann NY Acad Sci 899: 274-282.
16. Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo AA. (2004). Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem 89: 134-141.
17. Lallemand D, Spyrou G, Yaniv M, Pfarr CM. (1997). Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts. Oncogene 14: 819-830.
18. Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L et al. (2006). Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318: 1375-1387.
19. Maccarrone M, Di Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A et al. (2003). The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278: 33896-33903.
20. Malumbres M, Barbacid M. (2001). To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222-231.
21. Mechta F, Lallemand D, Pfarr CM, Yaniv M. (1997). Transformation by ras modifies AP1 composition and activity. Oncogene 14: 837-847.
22. Mechta-Grigoriou F, Gerald D, Yaniv M. (2001). The mammalian Jun proteins: redundancy and specificity. Oncogene 20: 2378-2389.
23. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M. (1994). Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76: 747-760.
24. Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A. (2006). Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281: 14841-14851.
25. Sarnataro D, Pisanti S, Santoro A, Gazzerro P, Malfitano AM, Laezza C et al. (2006). The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. Mol Pharmacol 70: 1298-1306.
26. Stickeler E, Kittrell F, Medina D, Berget SM. (1999). Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18: 3574-3582.
27. van Dam H, Duyndam M, Rottier R, Bosch A, de Vries-Smits L, Herrlich P et al. (1993). Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J 12: 479-487.
28. Weitzman JB, Fiette L, Matsuo K, Yaniv M. (2000). JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell 6: 1109-1119.
29. Zhao Q, He Z, Chen N, Cho YY, Zhu F, Lu C et al. (2005). 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. J Biol Chem 280: 26735-26742.